Josef Finsterer, MD, PhD*, Marlies Frank, MD, “Evidence level for effectiveness of glucagon-like peptide-1 receptor agonists respectively sodium glucose co-transporter-2 inhibitors for mitochondrial diabetes is low”, ijmhs, vol. 10, no. 06, pp. 959–960, Jun. 2020.